Stockreport

Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update

Cardiff Oncology, Inc.  (CRDF) 
PDF - In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support o [Read more]